Our analysis did not detect a difference between IDH mutant and IDH WT tumors with regards to metastatic disease, however, it is important to note that most studies reported overall survival but lacked data on time to metastasis or time to disease recurrence, which limited this evaluation. This evidence concerns the gene IDH2 and metastatic neoplasm.